/Companies

InterCure Ltd.

NASDAQ: INCR

Hertzliya · 1 known investors

Find your way into InterCure Ltd.

Sign up to see every warm intro you have to InterCure Ltd.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the InterCure Ltd. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

InterCure produces, manufactures, and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use in licensed markets including Israel, the European Union, and Australia, and operates a chain of over 25 licensed pharmacies across Israel, the UK, and Austria that specialize in medical cannabis dispensing.

Founders & leadership

AR
Alexander RabinovichExecutive
ACAmos Cohen
Amos CohenChief Financial Officer
BCBarak Cohen
Barak CohenBarak Cohen has over 20 years of management experience, with more than 7 years in the medical cannabis and pharmaceutical sector. He currently serves as CEO of an InterCure subsidiary overseeing medical cannabis distribution operations and trading houses across multiple departments.

Board

DS
David SaltonBoard director
LM
Lennie Michelson GrinbaumBoard director
GH
Gideon HirschfeldBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements
▶Undisclosed amountofferedAug 2026 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander RabinovichExecutive Officer, Director
  • David SaltonDirector
  • Lennie Michelson GrinbaumDirector
  • Gideon HirschfeldDirector
  • Amos CohenExecutive Officer
First sale
Jun 2026
Incorporated
Corporation, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does InterCure Ltd. do?
InterCure produces, manufactures, and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use in licensed markets including Israel, the European Union, and Australia, and operates a chain of over 25 licensed pharmacies across Israel, the UK, and Austria that specialize in medical cannabis dispensing.
Who are InterCure Ltd.'s investors?
InterCure Ltd.'s investors include Nippon Venture Capital.
Where is InterCure Ltd. headquartered?
InterCure Ltd. is headquartered in Hertzliya.